“FDA approval of this innovative study design is a significant milestone. Pharmaceutical companies have been worried that the FDA would not accept telemonitoring in place of costly clinic visits,” said John Holland, senior vice president for research and business development at AMC Health. U.S. Food and Drug Administration Approves Remote Monitoring for Drug Trial. ThirdAge.com (3 pages)
Sign up for our weekly alerts emails - the easiest way to keep up to date!
Most Recent Comments